How COVID-19 Impacting AI for Drug Discovery Market? Top Key Players: Atomwise, Inc., Insilico Medicine, Numerate
Click to get AI for Drug Discovery Market Research Sample PDF Copy Instantly @: https://www.theinsightpartners.com/sample/TIPRE00004177/?source=openpr-10271
What is AI for Drug Discovery?
Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.
The AI for drug discovery market is expected to grow during the forecast period due to the increasing number of cross-industry partnerships & collaborations, a significant growth in venture capital investments, rise in importance of drug discovery and increase in funding of the R&D activities for the use of AI technology in the field of drug discovery. However, limited awareness, unwillingness among medical practitioners to adopt AI-based technologies, unclear regulatory guidelines for medical software and lack of interoperability among AI solutions offered by different vendors are likely to hamper the growth of the market in the forecast period.
The Emerging Players in the AI for Drug Discovery Market includes
Cloud Pharmaceuticals, Inc.
An Overview of the Impact of COVID-19 on this Market:
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the AI for Drug Discovery Market which would mention How the Covid-19 is Affecting the AI for Drug Discovery Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for AI for Drug Discovery Players to fight Covid-19 Impact.
The research provides answers to the following key questions:
What is the estimated growth rate of the market for the forecast period 2020–2027? What will be the market size during the estimated period?
What are the key driving forces responsible for shaping the fate of the AI for Drug Discovery market during the forecast period?
Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the AI for Drug Discovery market?
What are the prominent market trends influencing the development of the AI for Drug Discovery market across different regions?
What are the major threats and challenges likely to act as a barrier in the growth of the AI for Drug Discovery market?
What are the major opportunities the market leaders can rely on to gain success and profitability?
The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the AI for Drug Discovery market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments. The report predicts the influence of different industry aspects on the AI for Drug Discovery market segments and regions.
AI for Drug Discovery Market: Regional analysis includes:
Asia-Pacific Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
North America (The United States, Mexico, and Canada.)
South America (Brazil etc.)
The Middle East and Africa (GCC Countries and Egypt.)
This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the AI for Drug Discovery market.
Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure @ https://www.theinsightpartners.com/buy/TIPRE00004177/?source=openpr-10271
The Insight Partners,
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release How COVID-19 Impacting AI for Drug Discovery Market? Top Key Players: Atomwise, Inc., Insilico Medicine, Numerate here
News-ID: 2273642 • Views: 741
More Releases from The Insight Partners
Clinical Trial Supplies Market is Booming Worldwide According to New Research Re …
According to The Insight Partners market research study of 'Clinical Trial Supplies Market to 2027 - Global Analysis and Forecasts by Product & Service, Stage, Drug Type, and Application.' The global clinical trial supplies market is expected to reach US$ 3,298.91 Mn in 2027 from US$ 1,867.44 Mn in 2019. The market is estimated to grow with a CAGR of 7.4% from 2020-2027. The report provides trends prevailing in the
Genetic Modification Therapies Market Growth and Demand Analysis By Global Top K …
Genetic Modification Therapies Market report focuses on providing a market overview, which interprets value chain structure, industrial environment, regional analysis, applications, and forecast from 2030. The report also offers the most accurate estimations and forecasts possible. In addition, this study emphasizes detailed competition analysis on market prospects, especially growth strategies that market experts claim. Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00018012/?utm_source=OpenPR&utm_medium=10129 Genetic modification therapy incorporates a functional
Dental Milling Machine Market by Product, Size, Segments, Global Volume, Top Com …
The Insight Partners has added Latest Report on "Dental Milling Machine Market" Size To 2028. Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production
Low GWP refrigerants Market Worth US$ 49.89 billion by 2028 by Focusing Global I …
The Low GWP refrigerants market is expected to grow from US$ 22.99 billion in 2021 to US$ 49.89 billion by 2028 at a CAGR of 11.7% between 2022 and 2028. The Low GWP refrigerants Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at:
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug